Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin.
Neuroinflammation: The Devil is in the Details.
[Antidepressants for treatment of depression in palliative patients : A systematic literature review.]
Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated.
Automatic brain MR images diagnosis based on edge fractal dimension and spectral energy signature.
Multiple sclerosis: Benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter.
Conventional housing conditions attenuate the development of experimental autoimmune encephalomyelitis.
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS)
Home or away? Choosing a setting for a falls-prevention program for people with multiple sclerosis.
Mir-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization.
Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway.
Non-human primate models of multiple sclerosis.
Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting.
[New challenges in multiple sclerosis treatment].
A possible case of acute disseminated encephalomyelitis after Japanese encephalitis.
The immunomodulatory oligodendrocyte.
Molecular approach to targeted therapy for multiple sclerosis.
Oligodendroglial Argonaute protein Ago2 associates with molecules of the Mbp mRNA localization machinery and is a downstream target of Fyn kinase.
Extracts from Dendropanax morbifera Leaves Have Modulatory Effects on Neuroinflammation in Microglia.
Therapeutic strategies targeting B-cells in multiple sclerosis.
Participant perceptions of a novel physiotherapy approach ("Blue Prescription") for increasing levels of physical activity in people with multiple sclerosis: a qualitative study following intervention.
Circulating Levels of Interleukin-35 in Patients with Multiple Sclerosis: Evaluation of the Influences of FOXP3 Gene Polymorphism and Treatment Program.
Drawing on related knowledge to advance multiple sclerosis falls-prevention research.
Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis.
Immunoglobulin GM allotypes in multiple sclerosis.

Pages